Vetoquinol 

€80.9
20
-€1.6-1.94% Wednesday 15:30

Statistics

Day High
82.5
Day Low
80.6
52W High
91
52W Low
69.2
Volume
1,336
Avg. Volume
-
Mkt Cap
961.25M
P/E Ratio
16.47
Dividend Yield
1.1%
Dividend
0.89

Upcoming

Dividends

1.1%Dividend Yield
Jun 25
€0.89
Jun 24
€0.85
Jun 23
€0.8
Jun 22
€0.8
Jun 21
€0.5
10Y Growth
8.06%
5Y Growth
12.22%
3Y Growth
3.62%
1Y Growth
N/A

Earnings

27MarExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

10.88%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.08BRevenue
117.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VETO.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap51.66B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing with Vetoquinol's product range.
Elanco Animal Health
ELAN
Mkt Cap11.83B
Elanco Animal Health Incorporated operates in the same industry, providing a comprehensive range of health products for animals, which puts it in direct competition with Vetoquinol.
Bayer
BAYRY
Mkt Cap47.55B
Bayer AG's Animal Health division offers veterinary drugs and products, competing in the same market as Vetoquinol, especially in the areas of parasiticides and anti-infectives.
Phibro Animal Health
PAHC
Mkt Cap2.29B
Phibro Animal Health Corporation produces animal health and mineral nutrition products, competing with Vetoquinol in the provision of pharmaceuticals and nutritional products for animals.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc., through its animal health division, competes with Vetoquinol by offering a wide range of veterinary products and services, including vaccines and pharmaceuticals for various animal species.
Idexx Laboratories
IDXX
Mkt Cap46.92B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, livestock, and poultry services, competing with Vetoquinol in the animal health diagnostics market.
Pfizer
PFE
Mkt Cap156.77B
Pfizer Inc., through its Zoetis division (now a separate company), was a direct competitor in the animal health industry, offering a range of pharmaceuticals that compete with Vetoquinol's offerings.
Abbott Laboratories
ABT
Mkt Cap168.23B
Abbott Laboratories, with its range of veterinary diagnostic instruments and tests, competes in the broader animal health market, impacting companies like Vetoquinol that also operate in animal health diagnostics and treatment.

About

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Show more...
CEO
Mr. Matthieu Frechin
Employees
2497
Country
France
ISIN
FR0004186856

Listings

0 Comments

Share your thoughts

FAQ

What is Vetoquinol stock price today?
The current price of VETO.PA is €80.9 EUR — it has decreased by -1.94% in the past 24 hours. Watch Vetoquinol stock price performance more closely on the chart.
What is Vetoquinol stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vetoquinol stocks are traded under the ticker VETO.PA.
Is Vetoquinol stock price growing?
VETO.PA stock has risen by +2.28% compared to the previous week, the month change is a +2.66% rise, over the last year Vetoquinol has showed a +5.34% increase.
What is Vetoquinol market cap?
Today Vetoquinol has the market capitalization of 961.25M
What is Vetoquinol revenue for the last year?
Vetoquinol revenue for the last year amounts to 1.08B EUR.
What is Vetoquinol net income for the last year?
VETO.PA net income for the last year is 117.37M EUR.
Does Vetoquinol pay dividends?
Yes, VETO.PA dividends are paid annual. The last dividend per share was 0.89 EUR. As of today, Dividend Yield (FWD)% is 1.1%.
How many employees does Vetoquinol have?
As of April 23, 2026, the company has 2,497 employees.
In which sector is Vetoquinol located?
Vetoquinol operates in the Health & Wellness sector.
When did Vetoquinol complete a stock split?
Vetoquinol has not had any recent stock splits.
Where is Vetoquinol headquartered?
Vetoquinol is headquartered in Lure, France.